Titlebook: Drug Delivery and Targeting; Monika Sch?fer-Korting,Ulrich S. Schubert Book 2024 The Editor(s) (if applicable) and The Author(s), under ex

Encephalitis

稀釋前

HAVOC

New Therapeutic Options in Pulmonal Diseases: Sphingolipids and Modulation of Sphingolipid Metabolisiscussed. Only such an understanding opens up the possibility of developing new therapeutic strategies with the aim of correcting the imbalance in sphingolipid metabolism and signaling. Such delivery strategies have already been studied in animal models of these lung diseases, demonstrating that tar

Ornithologist

RNA Delivery to Mitochondriahat delivers nucleic acids including RNA to mitochondria is required, but efforts in this area have been limited compared to research targeting the nucleus and cytoplasm. This contribution provides an overview of mitochondria-targeted gene therapy strategies and discusses studies that have attempted